Home › Heart Failure › NCT07098858

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

Who can join

Ages 22 and older · All sexes

* Patient or legally authorized representative can provide written authorization and/or consent per institution requirements.
* Patient is intended to receive a WiSE System and passed the acoustic window screening
* Patient who is, or will be, accessible for follow-up.
* Participation is not excluded by local law.
* Patient is not enrolled in a concurrent drug and/or device study that may confound the Registry results.
* Patient life expectancy \>1 year.

About the study

Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System

What is being tested

• The Wise System (device)

Sponsor: EBR Systems, Inc. · Participants: 320 · Started: Nov 3, 2025

Contact the study team

• Jamie Burke · Phone: 17194644185

Official record on ClinicalTrials.gov — NCT07098858

Locations in the U.S.

Conditions

• Heart Failure

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.